These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12609532)

  • 1. Single step enrichment of blood dendritic cells by positive immunoselection.
    López JA; Bioley G; Turtle CJ; Pinzón-Charry A; Ho CS; Vuckovic S; Crosbie G; Gilleece M; Jackson DC; Munster D; Hart DN
    J Immunol Methods; 2003 Mar; 274(1-2):47-61. PubMed ID: 12609532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy.
    Radford KJ; Turtle CJ; Kassianos AJ; Vuckovic S; Gardiner D; Khalil D; Taylor K; Wright S; Gill D; Hart DN
    J Immunother; 2005; 28(4):322-31. PubMed ID: 16000950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.
    Hock BD; Starling GC; Daniel PB; Hart DN
    Immunology; 1994 Dec; 83(4):573-81. PubMed ID: 7875738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses.
    Freeman JL; Vari F; Hart DN
    J Immunother; 2007 Oct; 30(7):740-8. PubMed ID: 17893566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma.
    Vari F; Munster DJ; Hsu JL; Rossetti TR; Mahler SM; Gray PP; Turtle CJ; Prue RL; Hart DN
    Br J Haematol; 2008 Nov; 143(3):374-7. PubMed ID: 18729856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMRF-44 antibody-mediated depletion of activated human dendridic cells: a potential means for improving allograft survival.
    Koppi T; Munster DJ; Brown L; MacDonald KP; Hart DN
    Transplantation; 2003 May; 75(10):1723-30. PubMed ID: 12777863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56.
    Hock BD; Fearnley DB; Boyce A; McLellan AD; Sorg RV; Summers KL; Hart DN
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):320-34. PubMed ID: 10323336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.
    Fromm PD; Papadimitrious MS; Hsu JL; Van Kooten Losio N; Verma ND; Lo TH; Silveira PA; Bryant CE; Turtle CJ; Prue RL; Vukovic P; Munster DJ; Nagasaki T; Barnard RT; Mahler SM; Anguille SA; Berneman Z; Horvath LG; Bradstock KF; Joshua DE; Clark GJ; Hart DN
    Oncoimmunology; 2016 Jun; 5(6):e1168555. PubMed ID: 27471645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway.
    Monji T; Petersons J; Saund NK; Vuckovic S; Hart DN; Auditore-Hargreaves K; Risdon G
    Immunol Cell Biol; 2002 Jun; 80(3):216-25. PubMed ID: 12067408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.
    Fearnley DB; McLellan AD; Mannering SI; Hock BD; Hart DN
    Blood; 1997 May; 89(10):3708-16. PubMed ID: 9160676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-DC8+ leukocytes--a novel human dendritic cell population.
    Schäkel K; Poppe C; Mayer E; Federle C; Riethmüller G; Rieber EP
    Pathobiology; 1999; 67(5-6):287-90. PubMed ID: 10725804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy.
    Alejandro López J; Crosbie G; Kelly C; McGee AM; Williams K; Vuckovic S; Schuyler R; Rodwell R; Wright SJ; Taylor K; Hart DN
    J Immunol Methods; 2002 Sep; 267(2):199-212. PubMed ID: 12165441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and function of human dendritic cells derived from M-DC8(+) monocytes.
    de Baey A; Mende I; Riethmueller G; Baeuerle PA
    Eur J Immunol; 2001 Jun; 31(6):1646-55. PubMed ID: 11385608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of the conditions for generating human DC initiated antigen specific T lymphocyte lines in vitro.
    Mannering SI; McKenzie JL; Hart DN
    J Immunol Methods; 1998 Oct; 219(1-2):69-83. PubMed ID: 9831389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines.
    Ho CS; Munster D; Pyke CM; Hart DN; López JA
    Blood; 2002 Apr; 99(8):2897-904. PubMed ID: 11929780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype.
    McLellan AD; Heiser A; Sorg RV; Fearnley DB; Hart DN
    J Invest Dermatol; 1998 Nov; 111(5):841-9. PubMed ID: 9804348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen.
    Zhong RK; Donnenberg AD; Zhang HF; Watkins S; Zhou JH; Ball ED
    J Immunol; 1999 Aug; 163(3):1354-62. PubMed ID: 10415035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
    Meyer-Wentrup F; Burdach S
    J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.